These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29354798)

  • 1. Activity of Factor XII-Locarno.
    Mohammed BM; Ivanov I; Matafonov A; Emsley J; Gailani D
    Res Pract Thromb Haemost; 2018 Jan; 2(1):168-173. PubMed ID: 29354798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-chain factor XII: a new form of activated factor XII.
    Ivanov I; Matafonov A; Gailani D
    Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A site on factor XII required for productive interactions with polyphosphate.
    Shamanaev A; Litvak M; Cheng Q; Ponczek M; Dickeson SK; Smith SA; Morrissey JH; Gailani D
    J Thromb Haemost; 2023 Jun; 21(6):1567-1579. PubMed ID: 36863563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
    Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
    Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA; Furlan M; Stricker H; Lämmle B
    Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic activity of contact factor zymogens.
    Shamanaev A; Emsley J; Gailani D
    J Thromb Haemost; 2021 Feb; 19(2):330-341. PubMed ID: 33107140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease activity in single-chain prekallikrein.
    Ivanov I; Verhamme IM; Sun MF; Mohammed B; Cheng Q; Matafonov A; Dickeson SK; Joseph K; Kaplan AP; Gailani D
    Blood; 2020 Feb; 135(8):558-567. PubMed ID: 31800958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains.
    Shamanaev A; Ivanov I; Sun MF; Litvak M; Srivastava P; Mohammed BM; Shaban R; Maddur A; Verhamme IM; McCarty OJT; Law RHP; Gailani D
    Blood Adv; 2022 May; 6(10):3142-3154. PubMed ID: 35086137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
    Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
    J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XII in coagulation, inflammation and beyond.
    Didiasova M; Wujak L; Schaefer L; Wygrecka M
    Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation.
    Clermont AC; Murugesan N; Edwards HJ; Lee DK; Bayliss NP; Duckworth EJ; Pethen SJ; Hampton SL; Gailani D; Feener EP
    Front Pharmacol; 2023; 14():1287487. PubMed ID: 38178859
    [No Abstract]   [Full Text] [Related]  

  • 13. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
    Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyphosphate, Zn
    Wang Y; Ivanov I; Smith SA; Gailani D; Morrissey JH
    J Thromb Haemost; 2019 Dec; 17(12):2131-2140. PubMed ID: 31420909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
    Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI
    J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
    Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
    Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in factor XII structure and function.
    Shamanaev A; Litvak M; Gailani D
    Curr Opin Hematol; 2022 Sep; 29(5):233-243. PubMed ID: 35916558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XII truncation accelerates activation in solution.
    de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
    J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg 353-->Pro leading to loss of a kallikrein cleavage site.
    Hovinga JK; Schaller J; Stricker H; Wuillemin WA; Furlan M; Lämmle B
    Blood; 1994 Aug; 84(4):1173-81. PubMed ID: 8049433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.